Facing this high frequency in our African Caribbean population and the functional importance of this receptor, we aimed at understanding whether the non SLE African Caribbean control group has a protective factor against FCGR2B-232T. The gene discussed is FCGR2B; the disease is systemic lupus erythematosus.